James E Flynn insider trades
Open-market stock purchases and sales by James E Flynn, Director, 10% Owner at Nuvalent, Inc, from SEC Form 4 filings since Aug 5, 2014.
Track record: 18% of 93 scored buys are up 5% or more since purchase, averaging -19%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jul 15, 2026 | NUVL Nuvalent, Inc | Sold (not open market) | $1B |
| Jul 15, 2026 | NUVL Nuvalent, Inc | Sold (not open market) | $80.6M |
| Jul 15, 2026 | NUVL Nuvalent, Inc | Sold (not open market) | $638K |
| Jul 15, 2026 | NUVL Nuvalent, Inc | Sold (not open market) | $427K |
| Jul 15, 2026 | NUVL Nuvalent, Inc | Sold (not open market) | $337M |
| Jul 15, 2026 | NUVL Nuvalent, Inc | Sold (not open market) | $731K |
| Jul 15, 2026 | NUVL Nuvalent, Inc | Sold (not open market) | $187K |
| Jul 15, 2026 | NUVL Nuvalent, Inc | Sold (not open market) | $670K |
| Jul 15, 2026 | NUVL Nuvalent, Inc | Sold (not open market) | $303K |
| Jul 15, 2026 | NUVL Nuvalent, Inc | Sold (not open market) | $313K |
| Jun 16, 2026 | NUVL Nuvalent, Inc | Bought (not open market) | — |
| Jun 11, 2026 | PBLS Parabilis Medicines, Inc | Bought (not open market) | — |
| Jun 11, 2026 | PBLS Parabilis Medicines, Inc | Bought (not open market) | — |
| Jun 11, 2026 | PBLS Parabilis Medicines, Inc | Bought (not open market) | — |
| Jun 11, 2026 | PBLS Parabilis Medicines, Inc | Bought (not open market) | — |
| Jun 11, 2026 | PBLS Parabilis Medicines, Inc | Bought (not open market) | — |
| Jun 11, 2026 | PBLS Parabilis Medicines, Inc | Bought (not open market) | — |
| Jun 11, 2026 | PBLS Parabilis Medicines, Inc | Bought (not open market) | — |
| Jun 11, 2026 | PBLS Parabilis Medicines, Inc | Bought (not open market) | — |
| May 19, 2026 | LRMR Larimar Therapeutics, Inc | Bought (not open market) | — |
| Feb 27, 2026 | LRMR Larimar Therapeutics, Inc | Bought | $5.4M |
| Feb 27, 2026 | LRMR Larimar Therapeutics, Inc | Bought | $4.2M |
| Feb 27, 2026 | LRMR Larimar Therapeutics, Inc | Bought | $10M |
| Feb 27, 2026 | LRMR Larimar Therapeutics, Inc | Bought | $5.4M |
| Nov 24, 2025 | NUVL Nuvalent, Inc | Sold | $35.4M |
Companies traded
- NUVL Nuvalent, Inc: 2 buys, 2 sales, last Jul 15, 2026
- PBLS Parabilis Medicines, Inc: other filings, last Jun 11, 2026
- LRMR Larimar Therapeutics, Inc: 13 buys, last May 19, 2026
- SPRY ARS Pharmaceuticals, Inc: 8 sales, last Jun 27, 2025
- PHGE BiomX Inc: other filings, last Apr 21, 2025
- AFIB Acutus Medical, Inc: 4 buys, last Jan 27, 2025
- BCAX Bicara Therapeutics Inc: 1 buy, last Sep 17, 2024
- AHCO AdaptHealth Corp: 5 sales, last Mar 12, 2024
- GUTS Fractyl Health, Inc: other filings, last Feb 6, 2024
- CMAX CareMax, Inc: other filings, last Nov 17, 2023
- ONCR Oncorus, Inc: 4 buys, 27 sales, last Dec 30, 2022
- MIRM Mirum Pharmaceuticals, Inc: 1 buy, 10 sales, last Jun 6, 2022